Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.

被引:10
作者
Barthelemy, Philippe [1 ]
Loriot, Yohann [2 ]
Thibault, Constance [3 ]
Gross-Goupil, Marine [4 ]
Eymard, Jean Christophe [5 ]
Voog, Eric [6 ]
Abraham Jaillon, Christine [7 ]
Le Moulec, Sylvestre [8 ]
Chasseray, Matthieu [9 ]
Gobert, Aurelien [10 ]
Auberger, Benjamin [11 ]
Viala, Caroline [12 ]
Cabart, Mathilde [13 ]
Kazan, Eyad [14 ]
Lorgis, Veronique [15 ]
Hilgers, Werner [16 ]
Josse, Constant [17 ]
Lambert, Prisca [18 ]
Solbes, Marie-Noelle [19 ]
Flechon, Aude [20 ]
机构
[1] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France
[2] Inst Cancerol Gustave Roussy, Villejuif, France
[3] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris Carpem, Paris, France
[4] Bordeaux Univ Hosp, Bordeaux, France
[5] Inst Cancerol Jean Godinot, Reims, France
[6] Clin Victor Hugo, ILC Grp, Le Mans, France
[7] Foch Hosp, Serv Oncol Med, Suresnes, France
[8] Grp Radiotherapie & Oncol Pyrenees, Clin Marzet, Pau, France
[9] Clin Pasteur, Ctr Finisterien Radiothe & Oncol, Brest, France
[10] St Gregoire Hosp, St Gregoire, France
[11] CHRU Brest, Inst Cancerol & Hematol ICH Hop, Morvan, France
[12] CHU Nantes, Nantes, France
[13] Inst Bergonie, Bordeaux, France
[14] Clin Louviere, Ramsay Hlth Grp, Dept Med Oncol, Lille, France
[15] Inst Cancerol Bourgogne, Dijon, France
[16] Avignon Provence Canc Inst, Avignon, France
[17] Exystat, Malakoff, France
[18] Pfizer Oncol, Paris, France
[19] Merck Sante SAS, Merck KGaA, Lyon, France
[20] Ctr Leon Berard, Lyon, France
关键词
261-492-3532-2370-7650-2700; 283-183-138-12099; 130-540-543-12277; 261-566-148-11298; 8; 6; 3; 1880; 3590; 4044; 260; 112; 176; 3224; 65; 62; 295; 10; 2; 1;
D O I
10.1200/JCO.2024.42.4_suppl.561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:561 / 561
页数:1
相关论文
empty
未找到相关数据